AnalystBro Research
Research
Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.
17 articles.
Bangladesh All Bangladesh research →
Company · DSE:ARGONDENIM · Textiles: woven denim fabric · Analysis · 31 Oct 2026
Argon Denims: FY2026 EPS fell to BDT 1.16 and nine-month gross margin to 8.3%, with export incentives at 41% of operating profit
An 18.38m-yard denim mill at Sreepur, Gazipur: nine-month FY2026 turnover fell 8.7%; operating cash flow of BDT 575m came with receivables down BDT 284m; yarn from a common-directorship sister company was BDT 2.47bn in FY2025.
Company · DSE:SHASHADNIM · Textiles: woven denim fabric · Analysis · 31 Oct 2026
Shasha Denims: FY2026 EPS fell to BDT 1.03 and gross margin dropped to 9.5% in nine months, while associates supplied 48% of pre-tax profit
A 28.8m-yard denim mill in the Dhaka EPZ: nine-month FY2026 revenue fell 5.6% and EPS to BDT 0.39; operating cash flow of BDT 1.74bn came with accounts payable up BDT 1.86bn, and work in progress rose to BDT 1.05bn on 85 imported looms.
Company · DSE:QUASEMIND · Engineering (batteries and consumer goods) · Analysis · 29 Oct 2026
Quasem Industries: batteries carry the sales, while Sunstone income and a Tk 131.9m interest bill decide the profit
Batteries are 74.2% of gross sales and gross margin rose to 24.5%, but FY2025 profit before tax of Tk 94.9m included Tk 48.0m from Sunstone LLC, financial expenses took Tk 131.9m and quartz exports fell 56.5%.
Company · DSE:SHARPIND · Textiles: yarn spinning · Analysis · 29 Oct 2026
Sharp Industries: a restarted cotton-yarn mill swung to a BDT 2.39 loss per share in FY2026 on negative gross margins and BDT 3bn of short-term debt
The 2023 merger with Samin Food & Beverage put 121,000 spindles back to work after the 2019 fire, but the mill ran at 58% of capacity, earned a thin spread, sold below cost in Q2 and Q3 FY2026, and moved to DSE's Z category on 25-Oct-2026 after a second year without a dividend.
Company · DSE:GENEXIL · Information technology · Analysis · 29 Oct 2026
Genex Infosys: Bangladesh's largest contact-centre operator grew revenue 12.8% a year, but BDT 3.5bn of bank debt now takes 56% of operating profit
Revenue rose from BDT 823m in FY2018 to BDT 1,913m in FY2025 on call-centre and software work, while BDT 3.7bn of equipment spending since FY2023 was funded mostly with short-term loans. FY2026 EPS was BDT 2.03 with a loss in the June quarter; the stock trades at 13.7x that EPS and 1.16x NAV.
Company · DSE:PREMIERCEM · Cement · Analysis · 29 Oct 2026
Premier Cement: the best gross margin of the four listed cement makers compared, eaten by interest and a turnover tax
Premier sold 2,816 kt in FY2025 at 49% utilisation and earned Tk 1,498 a tonne gross, but Tk 2.3bn of finance cost and an 84% tax rate left EPS at Tk 1.29. FY2026 EPS Tk 0.72; NCML and the power unit merged in January 2026.
Company · DSE:RUNNERAUTO · Autos & motorcycles · Analysis · 29 Oct 2026
Runner Automobiles: three-wheelers and Eicher trucks carry the group, but BDT 11.7bn of debt takes most of the operating profit
FY2026 EPS rose to BDT 1.70 from 0.90 on a strong fourth quarter; financial expenses were 16.9% of FY2025 revenue and operating profit covered them 1.07 times. Receivables have fallen from 504 to 233 days of sales since 2023.
Company · DSE:ORIONPHARM · Pharmaceuticals & healthcare · Analysis · 29 Oct 2026
Orion Pharma: power revenue fell 88% after the plant contracts expired, leaving a BDT 25.6bn debt load on a pharma business earning BDT 251m
FY2025 consolidated revenue fell 61.6% to BDT 4.08bn and the group lost BDT 415m. The auditor qualified its opinion over a restated UCB loan and a BDT 651m claim on an individual; the shares have been in DSE's Z category since 5-Feb-2025 over an unpaid dividend.
Company · DSE:NAVANAPHAR · Pharmaceuticals & healthcare · Analysis · 29 Oct 2026
Navana Pharmaceuticals: sales up 28% and factories at 98% of capacity, but interest takes half of operating profit
FY2025 net sales rose 28.2% to BDT 8.84bn and operating profit 45.4%, yet finance expenses of BDT 750m left a 5.5% net margin. Borrowings fell from BDT 5.27bn to BDT 3.78bn by March 2026; FY2026 EPS was BDT 5.93.
Company · DSE:MATINSPINN · Textiles: yarn spinning · Analysis · 29 Oct 2026
Matin Spinning Mills: an 88,400-spindle DBL Group captive spinner whose FY2026 EPS rose 35% to BDT 6.36, with 81% of yarn sold to sister companies
The yarn spread over cotton widened to BDT 149 a kg in FY2025, debt fell to 0.78x equity by March 2026 and the board declared 45% cash plus 10% stock for FY2026; the share price rose 81% from the end of April to 29 October 2026.
Company · DSE:MALEKSPIN · Textiles: yarn spinning · Analysis · 29 Oct 2026
Malek Spinning Mills: a 60,000-spindle mill whose garment subsidiary earns four-fifths of group profit; FY2026 EPS eased to BDT 6.93
J.M. Fabrics made BDT 1,140m of the group's BDT 1,439m profit in FY2025 while the parent's yarn spread over cotton narrowed to about BDT 69 a kg; bank debt fell to 0.70x equity by March 2026, and sponsors again waived the 10% cash dividend.
Company · DSE:SQUARETEXT · Textiles: yarn spinning · Analysis · 29 Oct 2026
Square Textiles: 174,000 spindles at 94% utilisation, but nine-month profit fell 70% in FY2026 as yarn prices dropped and interest rose
Volume grew 44% in two years and the yarn spread over cotton held near BDT 130 a kg, yet net debt of BDT 13.7bn and lower yarn prices cut nine-month FY2026 EPS to BDT 1.54 from 5.10; the full year closed at BDT 4.50 (DSE) and the 32% cash dividend was kept.
Company · DSE:ENVOYTEX · Woven fabric & denim · Analysis · 29 Oct 2026
Envoy Textiles: a full denim mill earning BDT 8.24 a share, with finance costs taking half of operating profit
Envoy ran its 52m-yard denim plant at 106% in FY2025 and kept EPS near BDT 8.2-8.4 in FY2026 as yarn exports halved; net debt fell to BDT 10.7bn, interest cover is 2.0x; P/E is 8.6x FY2026 EPS and P/B 1.17x.
Company · DSE:BESTHLDNG · Hotels, ports, shipping & real estate · Analysis · 29 Oct 2026
Best Holdings: Le Méridien earnings fell 77% in FY2025 as BDT 18bn of debt and bond interest hit the P&L
Revenue fell 29% to BDT 2.43bn after the July-August 2024 unrest, finance cost rose six-fold to BDT 493m, EPS was BDT 0.30 and no dividend was declared; BDT 18.7bn of hotel projects are still under construction.
Company · DSE:BEACONPHAR · Pharmaceuticals · Initiation · 29 Oct 2026
Beacon's profit doubled in FY2026, but 16% long-run returns support a fair value range of BDT 22–88 (base 52)
Fair value BDT 22–88 (base 52) vs price 92.7; general medicines drive ~13% sales growth and a second oncology plant is coming; TRIPS after LDC graduation and related-party loans are the risks.
Fair value ৳22–88 · price ৳92.70 (2026-10-29)
Company · DSE:ACMELAB · Pharmaceuticals · Initiation · 29 Oct 2026
ACME's debt took 48% of FY2025 operating profit, limiting fair value to BDT 65–137 (base 105)
Fair value BDT 65–137 (base 105) vs price 77.9; domestic sales grow ~11% and own API helps margins; a weaker taka on imported APIs and interest on BDT 23bn of debt are the risks.
Fair value ৳65–137 · price ৳77.90 (2026-10-29)
Company · DSE:RENATA · Pharmaceuticals · Initiation · 29 Oct 2026
Renata's FY2026 recovery is real, but a 10% return on equity supports BDT 146–350 a share (base 234)
Fair value BDT 146–350 (base 234) vs price 425.9 on 29-Oct-2026. FY2026 EPS rose 64% to BDT 31.76 as debt fell; DGDA price controls, a weaker taka on imported APIs and LDC/TRIPS are the risks.
Fair value ৳146–350 · price ৳425.90 (2026-10-29)